KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 8 analysts with an average price target of $198.17. This is a potential upside of $33.34 (20.23%) from yesterday's end of day stock price of $164.83.

Krystal Biotech's activity chart (see below) currently has 54 price targets and 66 ratings on display. The stock rating distribution of KRYS is 97.3% BUY and 2.7% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.43% with an average time for these price targets to be met of 298.36 days.

Highest price target for KRYS is $221, Lowest price target is $175, average price target is $198.17.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 18-Dec-2024. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 36 are a BUY (97.3%), 1 are a HOLD (2.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$212

$47.17 (28.62%)

$212

3 days ago
(18-Dec-2024)

7/9 (77.78%)

$43.47 (25.79%)

409

Buy

$221

$56.17 (34.08%)

$221

3 days ago
(18-Dec-2024)

25/30 (83.33%)

$52.47 (31.13%)

199

Buy

$220

$55.17 (33.47%)

$145

3 months 10 days ago
(11-Sep-2024)

2/3 (66.67%)

$21.21 (10.67%)

157

Buy

$180

3 months 22 days ago
(29-Aug-2024)

4/4 (100%)

$65.38 (57.04%)

139

Buy

$175

$10.17 (6.17%)

$130

9 months 24 days ago
(27-Feb-2024)

4/4 (100%)

$4.85 (2.85%)

135

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 298.36 days on average for the stock forecasts to be realized with a an average price target met ratio 93.43

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $56.17

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?